Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chadi Al-Nawakil, Jerome Tamburini, Valerie Bardet, Nicolas Chapuis, Edward Bourry, Christian Roux, Sophie Park, Sylvain Choquet, François Dreyfus & Didier Bouscary. (2008) Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy. Leukemia & Lymphoma 49:10, pages 2012-2014.
Read now
Read now
Ridvan Ali, Meral Beksac, Fahir Ozkalemkas, Vildan Ozkocaman, Atilla Ozkan, Tulay Ozcelik & Ahmet Tunali. (2007) Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia. Leukemia & Lymphoma 48:7, pages 1426-1428.
Read now
Read now
Articles from other publishers (9)
Binod Dhakal, Sagar Patel, Saulius Girnius, Lohith Bachegowda, Raphael Fraser, Omar Davila, Abraham S. Kanate, Amer Assal, Amr Hanbali, Asad Bashey, Attaphol Pawarode, César O. Freytes, Cindy Lee, David Vesole, Robert Frank Cornell, Gerhard C. Hildebrandt, Hemant S. Murthy, Hillard M. Lazarus, Jan Cerny, Jean A. Yared, Jeffrey Schriber, Jesus Berdeja, Keith Stockerl-Goldstein, Kenneth Meehan, Leona Holmberg, Melhem Solh, Miguel Angel Diaz, Mohamed A. Kharfan-Dabaja, Nosha Farhadfar, Qaiser Bashir, Reinhold Munker, Richard F. Olsson, Robert P. Gale, Ruthlee-Lu Bayer, Sachiko Seo, Saurabh Chhabra, Shahrukh Hashmi, Sherif M. Badawy, Taiga Nishihori, Wilson Gonsalves, Yago Nieto, Yvonne Efebera, Shaji Kumar, Nina Shah, Muzaffar Qazilbash, Parameswaran Hari & Anita D’Souza. (2020) Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. Leukemia 34:12, pages 3338-3347.
Crossref
Crossref
Taiga Nishihori, Sarah M. Abu Kar, Rachid Baz, Melissa Alsina, Jean-Luc Harousseau & Mohamed A. Kharfan-Dabaja. (2013) Therapeutic Advances in the Treatment of Primary Plasma Cell Leukemia: A Focus on Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 19:8, pages 1144-1151.
Crossref
Crossref
A Mahindra, M E Kalaycio, J Vela-Ojeda, D H Vesole, M-J Zhang, P Li, J R Berenson, J M Bird, A Dispenzieri, J L Gajewski, R P Gale, L Holmberg, S Kumar, R A Kyle, H M Lazarus, S Lonial, J Mikhael, G A Milone, R Munker, R Nath, S Saccaro, L Bik To, D T Vogl, B Wirk & P Hari. (2011) Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research. Leukemia 26:5, pages 1091-1097.
Crossref
Crossref
H Avet-Loiseau, M Roussel, L Campion, X Leleu, G Marit, H Jardel, M Dib, O Decaux, T Lamy, M Tiab, P Cony-Makhoul, A Banos, G Lepeu, F Lifermann, M Macro, B Kolb, C Hulin, D Caillot, C Traulle, C Mathiot & B Royer. (2011) Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience. Leukemia 26:1, pages 158-159.
Crossref
Crossref
Sumit Madan & Philip R. Greipp. 2011. Concise Guide to Hematology. Concise Guide to Hematology
287
306
.
Edward Libby, Dulcinea Candelaria‐Quintana, Hayan Moualla, Maryam Abdul‐Jaleel & Ian Rabinowitz. (2010) Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen. American Journal of Hematology 85:9, pages 733-734.
Crossref
Crossref
Dennis Carney & John Seymour. 2008. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
231
260
.
Béla Telek, Leonóra Méhes, Péter Batár, Attila Kiss & Miklós Udvardy. (2008) Effective PAD (bortezomib, doxorubicine, dexamethasone) treatment of a patient with plasma cell leukaemia developed after autologous stem cell transplantation. Orvosi Hetilap 149:41, pages 1957-1959.
Crossref
Crossref
Eirini Katodritou, Evgenia Verrou, Vassiliki Gastari, Christina Hadjiaggelidou, Evangelos Terpos & Konstantinos Zervas. (2008) Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: Do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?. Leukemia Research 32:7, pages 1153-1156.
Crossref
Crossref